These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26592060)

  • 1. Screening for Insulin Resistance in Polycystic Ovary Syndrome: Views of Physician Members of the American Society for Reproductive Medicine.
    Asante A; Omurtag K; Stewart EA; Coddington CC
    J Reprod Med; 2015; 60(9-10):371-7. PubMed ID: 26592060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists.
    Dhesi AS; Murtough KL; Lim JK; Schulkin J; McGovern PG; Power ML; Morelli SS
    Am J Obstet Gynecol; 2016 Nov; 215(5):579.e1-579.e5. PubMed ID: 27457114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists.
    Abdel-Rahman MY; Jackson LW; Rodewald KJ; Abdellah MA; Ismail SA; Hurd WW
    Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):178-81. PubMed ID: 22464207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China.
    Ma R; Zou Y; Wang W; Zheng Q; Feng Y; Dong H; Tan Z; Zeng X; Zhao Y; Deng Y; Wang Y; Sun A
    BMC Endocr Disord; 2021 Sep; 21(1):182. PubMed ID: 34488736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome.
    Ou HT; Chen PC; Wu MH
    J Formos Med Assoc; 2017 Feb; 116(2):80-89. PubMed ID: 27131512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Gabrielli L; de Almeida Mda C; Aquino EM
    Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey.
    Yan D; Yan-Fang W; Shi-Yang Z; Rui-Lin M; Xue-Song D; Xiao M; Wei X; Aijun S
    J Ovarian Res; 2021 Feb; 14(1):25. PubMed ID: 33536040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
    Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
    Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes.
    Ortiz-Flores AE; Luque-Ramírez M; Escobar-Morreale HF
    Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z; Krstevska B
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.